Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

News   May 16, 2018 | Original story from University of Arizona

 
Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

The inactive form (left) of the MAPK p38 enzyme moves in an uncoordinated fashion. Once the necessary molecules (blue blob and P symbols) bind, the enzyme becomes active (right) by moving in a coordinated fashion to do its job inside a cell. Credit: Senthil Ganesan, University of Arizona Department of Chemistry and Biochemistry.

 
 
 

RELATED ARTICLES

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

Availability of Brain Tumor Surgery Dye Increases for NHS Patients

News

A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to the National Institute for Health and Care and Excellence (NICE).

READ MORE

How Well Do Cancer Drugs Hit Their Targets? Here’s How to Find Out

News

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy